Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Nephropathies | 5 | 2019 | 53 | 2.790 |
Why?
|
| Epithelial Cells | 5 | 2019 | 366 | 1.940 |
Why?
|
| Kidney Glomerulus | 5 | 2018 | 80 | 1.930 |
Why?
|
| Kidney Tubules, Proximal | 3 | 2019 | 25 | 1.840 |
Why?
|
| Serum Albumin | 2 | 2018 | 49 | 1.270 |
Why?
|
| Endocytosis | 3 | 2018 | 104 | 1.260 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2017 | 87 | 1.130 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2017 | 88 | 1.100 |
Why?
|
| Cell Adhesion Molecules | 2 | 2019 | 70 | 1.090 |
Why?
|
| Rats, Zucker | 7 | 2019 | 22 | 0.950 |
Why?
|
| Podocytes | 2 | 2015 | 33 | 0.920 |
Why?
|
| Kidney Tubules | 2 | 2019 | 28 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2015 | 592 | 0.800 |
Why?
|
| Albuminuria | 2 | 2018 | 76 | 0.790 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 35 | 0.700 |
Why?
|
| Palmitic Acid | 1 | 2019 | 24 | 0.690 |
Why?
|
| Kidney | 2 | 2014 | 322 | 0.680 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2018 | 97 | 0.660 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2018 | 94 | 0.650 |
Why?
|
| Rats | 8 | 2019 | 3261 | 0.640 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 162 | 0.550 |
Why?
|
| Up-Regulation | 2 | 2018 | 490 | 0.550 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2015 | 21 | 0.550 |
Why?
|
| Albumins | 1 | 2015 | 24 | 0.530 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 49 | 0.530 |
Why?
|
| Cells, Cultured | 5 | 2018 | 1442 | 0.520 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2014 | 13 | 0.490 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.490 |
Why?
|
| Signal Transduction | 3 | 2019 | 1802 | 0.490 |
Why?
|
| Obesity | 2 | 2019 | 965 | 0.470 |
Why?
|
| Animals | 11 | 2021 | 14307 | 0.470 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 152 | 0.430 |
Why?
|
| PPAR alpha | 2 | 2014 | 42 | 0.430 |
Why?
|
| Apoptosis | 1 | 2019 | 1317 | 0.410 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 82 | 0.310 |
Why?
|
| Male | 9 | 2021 | 18870 | 0.310 |
Why?
|
| Enzyme Activation | 2 | 2018 | 423 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1530 | 0.250 |
Why?
|
| Blood Pressure | 1 | 2008 | 613 | 0.240 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 600 | 0.230 |
Why?
|
| Palmitates | 1 | 2019 | 13 | 0.180 |
Why?
|
| Blotting, Western | 2 | 2015 | 834 | 0.180 |
Why?
|
| Proteinuria | 1 | 2019 | 48 | 0.180 |
Why?
|
| Osteopontin | 1 | 2019 | 35 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 36 | 0.180 |
Why?
|
| Ischemia | 1 | 2019 | 45 | 0.170 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 70 | 0.170 |
Why?
|
| Caspase 3 | 1 | 2019 | 194 | 0.170 |
Why?
|
| Cell Line | 2 | 2019 | 1289 | 0.170 |
Why?
|
| Mice, Knockout | 1 | 2021 | 897 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2019 | 53 | 0.170 |
Why?
|
| RNA Interference | 1 | 2019 | 225 | 0.160 |
Why?
|
| Exosomes | 1 | 2019 | 97 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 257 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1534 | 0.150 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 391 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1300 | 0.150 |
Why?
|
| Cell Compartmentation | 1 | 2015 | 12 | 0.140 |
Why?
|
| Glucose | 1 | 2017 | 217 | 0.140 |
Why?
|
| Clathrin | 1 | 2015 | 19 | 0.140 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 105 | 0.130 |
Why?
|
| Lysosomes | 1 | 2015 | 80 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 185 | 0.130 |
Why?
|
| Cell Communication | 1 | 2015 | 93 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 91 | 0.130 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 5 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2014 | 49 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 48 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 605 | 0.120 |
Why?
|
| Mice | 1 | 2021 | 5668 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1152 | 0.100 |
Why?
|
| Hypertrophy | 1 | 2008 | 31 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2008 | 48 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2008 | 42 | 0.080 |
Why?
|
| Collagen Type IV | 1 | 2008 | 48 | 0.080 |
Why?
|
| Actins | 1 | 2008 | 142 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 859 | 0.070 |
Why?
|
| Humans | 2 | 2019 | 34853 | 0.060 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 7 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 47 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 26 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2019 | 89 | 0.040 |
Why?
|
| Cell Movement | 1 | 2019 | 545 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 569 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2019 | 386 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1149 | 0.030 |
Why?
|